MXC has no patents.... yet worth DOUBLE MDC... A2Milk patents look where that got a2m... 0.43c to 21$ paying a dividend.. Medlab grossly undervalued considering what it has and achieving with its cannabis medicines let alone Nanocelle in general.. Not to mention GW Pharma growth and take over.... puzzles me why MDC is one of the cheapest plays on ASX with most advance cannabis pain trials.
MXC has no patents.... yet worth DOUBLE MDC... A2Milk patents...
Add to My Watchlist
What is My Watchlist?